Evista е по- ефективен от плацебо за предотвратяване и лечение на остеопороза.
In the prevention of osteoporosis, women receiving Evista had an increase in bone density in the hip or spine of 1.6% over two years, and those receiving placebo had a decrease of 0.8%.